Company
Headquarters: Madison, WI, United States
Founded: 1995
Employees: 6,420
CEO: Mr. Kevin T. Conroy
$10.07 Billion
USD as of July 1, 2025
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $162.07 B |
Danaher | $144.92 B |
Siemens Healthineers AG | $64.17 B |
Lonza Group Ltd | $49.67 B |
IDEXX Laboratories, Inc. | $43.99 B |
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Last Financial Reports Date | March 31, 2025 |
Revenue TTM | $2.83 B |
EBITDA | $30.3 M |
Gross Profit TTM | $1.97 B |
Profit Margin | -36.06% |
Operating Margin | -11.53% |
Quarterly Revenue Growth | 10.90% |
Exact Sciences Corporation has the following listings and related stock indices.
Stock: NASDAQ: EXAS wb_incandescent
Stock: FSX: EXK wb_incandescent
Cologuard
Founder(s): Stanley Lapidus, Anthony P. Shuber
Kevin Conroy (Chairman, President & CEO) Graham Lidgard (Chief Science Officer)